46th annual European Academy of Facial Plastic Surgery (EAFPS) in Verona, Italy

VERONA, Italy (PRWEB)
July 06, 2023

Board-certified facial plastic surgeon Dr. Neil A. Gordon is honored to accept the invitation to present at the 46th annual European Academy of Facial Plastic Surgery (EAFPS) in Verona, Italy. Dr. Gordon will share multiple lectures and presentations on advanced topics, including his deep plane facelift techniques, at the European Academy of Facial Plastic Surgery on September 14-17, 2023, in Verona, Italy.

The European Academy of Facial Plastic Surgery (EAFPS) facilitates and contributes to creating a body of duly-qualified surgeons performing plastic and reconstructive surgery of the face and neck. The EAFPS 2023 will stimulate study, research, and scientific advancement in plastic and reconstructive surgery.

The 46th EAFPS event will occur in Verona, Italy, defined as The City of Love. The main goal of the European Academy of Facial Plastic Surgery EAFPS events is to bring the Academy closer to young surgeons and to empower them with the best education delivered by Masters of Surgery, who are part of the invited faculty for the meeting.

Colleagues and plastic surgeons from other national and international scientific societies and continents will attend the meetings. The EAFPS features elite medical professionals and top surgical specialists, including Dr. Neil A. Gordon, who will provide multiple presentations and lectures at EAFPS 2023.

Dr. Gordon is recognized globally for his advancements in facial plastic surgery. He will share his unique strategies and advanced skills in primary and revision facial plastic surgery, gained from cutting-edge research, hands-on expertise, and performing deep plane rhytidectomy for over 26 years. As a highly-respected surgeon and scholar, Dr. Gordon is honored to serve as an educator to colleagues and new surgeons, teaching his advanced techniques on multiple continents each year.

Awards and Recognition

Dr. Neil A. Gordon is a multi-board certified facial plastic surgeon who has received multiple rewards, including:

• 
  New York Magazine’s Best Doctor
• America’s Best Doctors by US News and World
• Top Doctors in the New York Metro area by Castle Connolly, LTD

Dr. Gordon is included in the following:

• Top 101 Doctors
• Best Doctors Inc.
• Best Doctors in America
• The Guide to America’s Top Physicians: Consumer Research Council of America.

Dr. Gordon has presented his research and specialized surgical techniques at numerous conferences throughout the US and the world, including:

• American Academy of Facial Plastic and Reconstructive Surgery Conferences
• Rejuvenation of the Aging Face Conference
• Various Societies
• Multispecialty Aesthetic Conference
• Annual Conference of the Australian Academy of Facial Plastic Surgery
• The International Synopsis of Facial Plastic Surgery
• Facialis Academy
• European Academy of Facial Plastic Surgery
• The International Society of Aesthetic Plastic Surgery

Dr. Gordon is a compassionate and caring doctor who dedicated his career to advancing facial rejuvenation. He is honored to present his deep plane facelift and facial rejuvenation advancements at the EAFPS 2023 in Verona, Italy.

Retreat at Split Rock in Wilton, CT

Dr. Gordon founded the New England Surgical Center, LLC. It is a state-licensed, outpatient, fully-accredited surgical center at the beautiful Retreat at Split Rock in Wilton, CT, and two other locations. The AAAASF fully accredits the surgical facility, which features the latest technology and complies with hospital-mandated regulations and inspections.

The surgical center at the Retreat at Split Rock is recognized for its gold standard in comfort, safety, and privacy standards. It sits on an elegant, private country estate that provides a place of tranquility and comfort for Dr. Neil Gordon’s patients following facial rejuvenation. Patients travel internationally to achieve exquisite, natural-looking facial surgery results made possible with Dr. Gordon’s years of study, extensive research, and decades of experience performing primary, revision, and secondary facial surgery.

Dr. Gordon focuses on individualized care and typically limits his schedule to one daily operation to encourage impeccable outcomes, minimizing swelling and bruising and ensuring an excellent recovery. Most of Dr. Gordon’s patients can return to their professional or social life In just 9 to 14 days because he specializes in rapid recovery.

The adjacent Inn at Split Rock allows patients to enjoy an anxiety-free recovery without travel stress. While the inn is not a medical recovery facility, it does provide unique recovery treatment options like oxygen therapy, nutritional support, and lymphatic massage to help each patient achieve unparalleled advantages leading to an uncomplicated recovery.

###

To learn more about board-certified facial plastic surgeon Dr. Neil A. Gordon, call (203) 834-7700 or visit The Retreat at Split Rock to schedule a consultation at The Retreat at Split Rock located in Wilton, CT, Greenwich, CT, or New York, NY.

Share article on social media or email:

Xtalks Life Science Webinars

A holistic approach to food safety and traceability, covering aspects like recall readiness, quality assurance checks, allergen management and lot tracking, is critical.

TORONTO (PRWEB)
July 06, 2023

In the face of mounting global food safety concerns, a pivotal webinar is set to address the major challenges and solutions within the industry. Featuring prominent experts from the field, Jack Payne, Solutions Consulting Director, Food and Beverage, Aptean, and Drew Pogones, Product Manager, Global Compliance, Aptean, the discussion will delve into the practicalities of holistic food safety and traceability.

Unsafe food is a major global health concern, causing more than 200 diseases and leading to 600 million people falling ill and 420,000 deaths every year, according to the World Health Organization. The food and beverage industry holds a unique responsibility to ensure the safety of the products they deliver to market. A holistic approach to food safety and traceability, covering aspects like recall readiness, quality assurance checks, allergen management and lot tracking, is critical.

With food safety regulations constantly evolving and consumers demanding greater transparency regarding the quality of their food, businesses need to implement tangible and measurable procedures. The right technology can provide the visibility, accountability and traceability management that businesses need to deliver safe, high-quality products.

The live webinar titled “Food Safety Management: Visibility, Accountability and Traceability” will be held on Thursday, July 20, 2023, at 1pm EDT (10am PDT). It is an endeavor made possible through the collaboration between Aptean, a global leader in industry-specific software solutions, and Xtalks, a platform renowned for its informative webinars across various industries.

For more information, or to register for this event, visit Food Safety Management: Visibility, Accountability and Traceability.

About Aptean

Aptean is one of the world’s leading providers of purpose-built, industry-specific software that helps manufacturers and distributors effectively run and grow their businesses. With both cloud and on-premise deployment options, Aptean’s products, services and unmatched expertise help businesses of all sizes to be Ready for What’s Next, Now®. Aptean is headquartered in Alpharetta, Georgia and has offices in North America, Europe and Asia-Pacific. To learn more about Aptean and the markets we serve, visit http://www.aptean.com.

Aptean and Ready for What’s Next, Now are Registered Trademarks of Aptean, Inc. All other company and product names may be trademarks of the respective companies with which they are associated.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Bola AI

AI solutions are reimagining the dental office experiences of the past into those that will be commonplace in the future.

BOSTON (PRWEB)
July 06, 2023

Bola Technologies, Inc. (Bola AI), a leading provider of voice-AI technology for dental professionals, has announced an exciting partnership with Pearl, the industry’s most advanced radiologic AI software provider. The union will make the best in cutting-edge artificial intelligence technology available to dentists everywhere in a preferred-pricing bundle that could save clients up to $2,000 off their first year of service.

Bola AI’s Voice Perio solution empowers dental staff to seamlessly enter periodontal data directly into client PMS and EHR systems in real time. It will pair with Pearl’s Second Opinion and Practice Intelligence software, which automatically read dental X-rays and deliver actionable clinical insights for higher-quality patient care and practice management.

“AI solutions are reimagining the dental office experiences of the past into those that will be commonplace in the future,” said Rushi Ganmukhi, founder and CEO of Bola AI. “As such, it’s exciting to partner with other companies that have also caught the vision of how AI can transform the dental experience. Pearl’s solutions are helping elevate the standard of care and proving to be a game-changer for dentists and patients alike. We expect this to be a positive partnership for both companies.”

“We founded Pearl with the belief that artificial intelligence can be a paradigm-shifting technology for dentistry, radically improving the accuracy, objectivity, efficiency and transparency of dental medicine,” said Ophir Tanz, CEO of Pearl. “Bola AI holds the same belief, and our partnership reflects that shared vision.”

AI and deep learning have made incredible strides in recent years, with computer vision, language processing and speech recognition achieving near-human levels. Bola AI’s Voice Perio solution delivers speech accuracy at 99% and allows for variable accents and flexible phrasing while filtering out background noise and nonclinical speech. Bola AI offers the first clinical voice assistant for the dental market to utilize this new age of technology while providing unprecedented ease of use and accuracy.

With regulatory clearance in over 100 countries, Pearl’s Second Opinion is the world’s most comprehensive chairside radiologic AI software. It detects pathologies and other conditions in patient X-rays in real time for patient-facing display, helping dentists ensure the accuracy of their X-ray evaluations and enabling them to better communicate diagnoses to patients. Practice Intelligence, Pearl’s practice-performance platform, applies those clinical AI capabilities in conjunction with patient treatment data to uncover insights that dentists and practice staff use for more-efficient scheduling, recall, procurement and clinical planning, raising their offices’ standard of care and weekly production.

The partnership between Bola AI and Pearl elevates accuracy and efficiency throughout the patient experience, from touch-free periodontal charting to case presentation and treatment acceptance. To learn more about what cost savings practices can achieve by combining these technologies, please visit https://bola.ai/partners/pearl-ai/.

About Bola AI

Bola AI is the leader in voice-AI software for the dental practice. By harnessing the power of advanced technologies, this platform can provide efficient, fully integrated and accurate speech (99%) solutions for periodontal charting, clinical notes and more. With Bola AI, practices can empower themselves to create a smarter patient experience while improving operational efficiency and driving revenue. Headquartered in Boston, MA, Bola AI partners with Dentrix and Dentrix Ascend, Curve, Patterson and more. For more information, visit bola.ai.

About Pearl

Pearl is shaping the future of oral healthcare with AI solutions developed to elevate the efficiency, accuracy, quality and consistency of dental care. Launched in 2019, Pearl’s industry-leading computer-vision technology is the most comprehensive radiologic diagnostic aid cleared to detect numerous dental conditions across a broad range of patients. Pearl is helping dentists, practice owners and labs establish new, higher standards of dental care around the world. The company is the only dental AI software provider with multinational regulatory clearances, including in the US, the EU, Canada, Australia, New Zealand, the UAE, Saudi Arabia and Brazil. To learn more, visit http://www.hellopearl.com.

Share article on social media or email:

South Florida-based Memorial Healthcare System is a national leader in quality care and patient, physician, and employee satisfaction.

“Our workforce is the foundation of all we’re able to do and be for communities in South Florida, and we’re proud to be an employer that talented people want to be associated with.” – K. Scott Wester, CEO of Memorial Healthcare System

HOLLYWOOD, Fla. (PRWEB)
July 06, 2023

Modern Healthcare magazine has named Memorial Healthcare System one of its “2023 Best Places to Work in Healthcare.” The recognition honors employers that empower workers to provide patients and customers with the best possible care, products, and services.

Only 150 healthcare organizations nationwide made the publication’s list, which assesses employee satisfaction, in part, through an extensive survey process. A ranked listing of all the winners will be published in the October 2 issue of Modern Healthcare.

“Our workforce is the foundation of all we’re able to do and be for communities in South Florida, and we’re proud to be an employer that talented people want to be associated with,” said K. Scott Wester, CEO of Memorial Healthcare System. “We’re 15,000 strong, and the relationships we have with employees enables nearly everything we’ve accomplished.”

In its announcement, the magazine cited the extraordinary change healthcare is undergoing, and how having the right people in place is more critical than ever. Winning workplaces understand that taking care of employees is central to business success.

“An uncertain economy, staffing shortages, increasing demands for flexibility, and remote work opportunities are forcing every organization to focus on attracting and retaining talent in unprecedented ways,” said Dan Peres, president of Modern Healthcare. “The 2023 Best Places to Work winners proved the value of understanding what employees want, and need, today.”

The magazine will celebrate those receiving the honor at an awards gala taking place September 28 in Chicago.

                                                                                 # # #

South Florida-based Memorial Healthcare System (http://www.mhs.net) is a national leader in quality

care and patient, physician, and employee satisfaction. Its commitment to deeper caring and smarter health prioritizes a person-centered approach that has delivered safe, positive outcomes for 70 years.

Featuring multidisciplinary collaboration, research, innovation, and transparency within its many facilities, Memorial is focused on removing barriers, increasing access, and providing equitable care throughout the region. It employs a staff of more than 15,000 and operates six hospitals, numerous primary, urgent, and 24/7 care facilities, medical office buildings, a health specialty center, and nursing home.

To learn more, visit mhs.net and connect on Facebook, Twitter, Instagram, YouTube, and LinkedIn.

Share article on social media or email:

Xtalks Life Science Webinars

The speakers will also explore how comparator drug supply vendors manage complex trial designs and access to specialty drugs for the clinical trial.

TORONTO (PRWEB)
July 06, 2023

An important webinar titled “Fostering Patient-Centricity: Clinical Supply Chain Strategies and Sourcing Solutions” is set to take place on July 20, 2023. The event will explore current clinical trial industry trends, clinical supply strategies and the resulting implications for patients.

The discussion, featuring Samit Bhatt, Vice President, Clinical Trial Patient Solutions at Myonex, Todd Luckritz, Associate Director, Clinical Trial Patient Solutions at Myonex, and Racheal Yoon, Associate Director, Clinical Trial Patient Solutions at Myonex, will delve into the various clinical trial supply options. It will detail how these options can address the needs and priorities of sponsors, and the advantages and disadvantages they bring for sponsors, patients and sites. The speakers will also explore how comparator drug supply vendors manage complex trial designs and access to specialty drugs for the clinical trial.

A significant highlight of the event is the presentation of Myonex’s CTRx service, a pharmacy network solution that offers a local sourcing strategy. CTRx is designed to put patients and sites first, reducing costs and minimizing waste. This service can meet clinical trial comparator sourcing requirements, including for decentralized and direct-to-patient studies, and can work with sponsors to offer direct-to-patient solutions for sponsor-supplied IMPs in select countries.

The event is a result of a collaborative effort between Myonex, a leading global complete clinical trial supply company offering tailored solutions, and Xtalks. Myonex offers customized services in drug sourcing, packaging & distribution, equipment & supplies and patient solutions to meet the specific requirements and complexities of each trial. This partnership aims to provide a comprehensive solution for clinical trial supply needs, further promoting patient-centricity in the industry.

The webinar is a must-attend for those looking to learn more about innovative and on-demand local sourcing solutions, ways to minimize cost and waste in clinical trials and how a sourcing strategy focused on patient-centricity can prioritize sites and patients.

The live webinar will be held on Thursday, July 20, 2023, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Fostering Patient-Centricity: Clinical Supply Chain Strategies and Sourcing Solutions.

ABOUT MYONEX

Myonex is a leading global complete clinical trial supply company offering tailored solutions in drug sourcing, packaging & distribution, equipment & supplies, and patient solutions for each trial’s specific requirements and complexities. We partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), and other clinical trial service providers seeking a flexible, comprehensive solution for their trial supply needs.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Xtalks Life Science Webinars

The webinar aims to shed light on the key factors contributing to the failure of neuroscience trials and to offer effective risk detection strategies.

TORONTO, Ontario (PRWEB)
July 06, 2023

A new educational webinar is set to take the stage, addressing the significant challenges in neuroscience trials and offering strategies for enhancing success rates.

Neuroscience trials face unique difficulties due to the complexity of the brain, the most intricate organ in the body. These trials often struggle with the lack of reliable biomarkers, subjective outcome parameters and high placebo response rates. The webinar will explore these issues and discuss the role of early risk detection in increasing the chances of success in clinical studies.

Dr. Andreas Schreiner, MD, Senior Vice President of Medical Affairs, Neuroscience and Analgesia at Premier Research, and Adam Simmons, Executive Director of Program Strategy, Neuroscience at Premier Research, will share their knowledge and expertise in this event. The webinar aims to shed light on the key factors contributing to the failure of neuroscience trials and to offer effective risk detection strategies.

Premier Research, a global clinical research company, is committed to helping innovators transform life-changing ideas and breakthrough science into new medical treatments. The company leverages innovative technologies for smart study design and trial management, delivering clean and conclusive data to sponsors. Premier Research is devoted to addressing the unmet needs of patients across a broad range of medical conditions.

This event is the latest in a series of collaborations between Premier Research and Xtalks, reflecting their shared dedication to spreading knowledge and encouraging innovative thinking within the scientific and medical communities.

The live webinar, titled “Risk Detection in Neuroscience Trials: Are You Missing Early Warning Signs?” is scheduled for Thursday, July 20, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Risk Detection in Neuroscience Trials: Are You Missing Early Warning Signs?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Gulf Medical

JUPITER, Fla. (PRWEB)
July 06, 2023

An upcoming segment of Advancements with Ted Danson will examine innovations taking place throughout the surgical landscape.

Scheduled to broadcast in Q3, 2023, the segment will uncover some of the major issues taking place throughout the surgical industry today. Viewers will learn how problems with compromised vision can prolong surgery and increase stress levels, placing further burden on surgeons and risking the possibility of impacting patient safety.

The show will explore how Gulf Medical Technologies (GMT) is revolutionizing the world of surgical vision as it uncovers how developments in technology are unlocking the future potential of robotic and minimally invasive surgeries.

“Compromised vision in surgery is a problem that has persisted for decades. The fact that no clear solution exists speaks to its complexity. At Gulf Medical Technologies, we’ve dissected this issue to its core, and approached it from a unique angle, illuminating the blind spot we believe has been overlooked in past efforts. We are not only shaping the future of surgical vision, but we are redefining what it means to ‘see’ in the world of surgery,” said Ahmad Nabeel, MD, Founder & CEO, Gulf Medical Technologies.

Audiences will hear how GMT’s cutting-edge Klens technology minimizes unnecessary risks, making operating in robotic and laparoscopic surgeries more seamless.

“The technology sets the stage for the future of AI and robotic capabilities throughout the surgical landscape,” said Richard Lubin, senior producer for the Advancements series. “We look forward to sharing this information with viewers.”

About Advancements and DMG Productions:

Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies. Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming for viewers and networks.

For more information, please visit http://www.AdvancementsTV.com or call 866-496-4065.

Share article on social media or email:

Dr. Akshay Sanan, MD, FACS

BOSTON (PRWEB)
July 06, 2023

The Boston Center for Facial Rejuvenation is pleased to welcome Akshay Sanan, MD, FACS, to our team. Dr. Sanan’s addition to our Boston practice will further enhance the comprehensive range of services offered by the Boston Center for Facial Rejuvenation, ensuring that patients continue to receive the highest level of care and satisfaction.

About Dr. Sanan

Dr. Sanan earned his medical degree from the prestigious seven-year accelerated medical program at Boston University and then underwent a five-year residency in head and neck surgery at Thomas Jefferson University in Philadelphia, which ranks among the top ten in the country. After completing his residency, Dr. Sanan was chosen as Stanford University’s sole Facial Plastic and Reconstructive Surgery fellow, where he also trained residents and medical students.

Dr. Sanan is dual-certified by the American Board of Facial Plastic and Reconstructive Surgery and the American Board of Otolaryngology-Head and Neck Surgery. His extensive training and experience make him an invaluable addition to the Boston Center for Facial Rejuvenation. Dr. Sanan practiced in Los Angeles and Beverly Hills for three years, where he developed a robust facial plastic surgery practice with an international clientele. He is excited to return to Boston, his hometown, and bring his experience and techniques to the New England community and beyond.

At the Boston Center for Facial Rejuvenation, Dr. Sanan will focus on rhinoplasty and facial cosmetic surgery, including the deep plane facelift and deep neck lift. However, he is trained and experienced in all facial rejuvenation surgeries, including lip lifts, buccal fat reduction, brow lifts, and blepharoplasty. He also offers the full spectrum of non-surgical treatments, including neuromodulators (Botox, Dysport), facial fillers (Juvederm, Restylane), microneedling with radiofrequency, and laser resurfacing. He employs a patient-centered approach, working closely with each individual to maintain an open dialogue and create a personalized treatment plan that achieves their desired results while preserving their unique facial characteristics. Dr. Sanan’s patients can expect exceptional results and personalized care in achieving their cosmetic goals.

Dr. Sanan is a proponent of prejuvenation, which focuses on delaying aging symptoms for as long as possible. Prejuvenation treatments are designed to increase collagen production, support elastin function, and preserve facial volume — all key signs of a younger appearance.

About the Boston Center for Facial Rejuvenation

The Boston Center for Facial Rejuvenation is a top-rated plastic surgery practice in Boston, offering a wide range of plastic surgery and cosmetic dermatology services. The center is led by a team of highly experienced, board-certified physicians, including Drs. Leonard Miller, Sean Doherty, Farah Moustafa, and Melissa Michelon.

They offer various non-surgical and surgical procedures for the face, neck, and body, such as Botox®, dermal fillers, blepharoplasty, liposuction, neck lift, tummy tuck, and breast augmentation. Additionally, the center provides advanced skincare treatments, including medical facials, chemical peels, and laser skin rejuvenation.

The Boston Center for Facial Rejuvenation is committed to providing excellent patient care and satisfaction by offering the latest advancements in plastic surgery and cosmetic dermatology. With the addition of Dr. Sanan, the center will continue to uphold its reputation for delivering outstanding results in rhinoplasty, deep plane facelift, and deep neck lift surgery.

For more information about Akshay Sanan, MD, FACS, and the services offered at the Boston Center for Facial Rejuvenation, please visit:

To schedule a consultation, please contact the center at https://www.bcffr.com/contact.

Share article on social media or email: